Central BioHub welcomes human biospecimens suppliers across the globe.
A 2017 establishment, Central BioHub is an online marketplace designed for buying and selling human biospecimens online. The objective is to globalise and streamline the acquisition of biological specimens for research. By establishing connections between international researchers and recognised human biospecimen suppliers globally, we draw on our vast experience in providing seamless biospecimen procurement solutions. Yes, Central BioHub makes it possible to find human specimens in minutes!
Research is crucial to preventing diseases and thwarting potential threats. Human biological specimens such as serum, plasma, CSF, cells, DNA, tissues, etc., collected from the patients are essential tools for discovering more about human diseases at the molecular level. As a result, Central BioHub launched an open-access web platform for simplified online procurement of human biospecimens for research and development. To expand the global biospecimen supplier network, Central BioHub is inviting international human biobanks and biorepositories to collaborate and share your priceless inventory with us in the hope that greater collaboration will result in ground-breaking discovery. Joining Central BioHub can benefit you in different ways. Click on the following link to learn more about us and the advantages of working with us: https://centralbiohub.de/blogs/join-our-global-supplier-network.
What to anticipate if you become a member of Central Bio Hub's supplier network:
The numerous special features of our next-generation human biospecimen marketplace will pique your excitement. We propose a successful partnership with us with the following benefits:
- Fast and legal clinical specimens acquisition
- Integrated Supplier Panel for inventory management
- International customer base
- High ethical standards
- complete control over your inventory and pricing
- 24/7 access to your banked human samples
- free guided supplier onboarding, and more
Central BioHub's trust in the market is rising.
Because of our superior services and commitment to transparent trade ralations, we stand out in the growing market for human bio specimens. Central BioHub offers no compromise on the quality of the human specimens we provide to the research community by strictly adhering to the highest ethical standards, the IRB-prescribed protocols, the Declaration of Helsinki and the Declaration of Taipei. In just five years, Central BioHub was able to gain the respect of scientists all over the world. Because of this, we have a history of working closely with the leading pharmaceutical, biotech, diagnostic, and clinical research organisations. We'll also have a successful working relationship with you as a supplier. Together, let's create a healthier future for the coming generations.
The global biobanks market size is expected to reach USD 74.54 billion by 2025 at a 4.5% CAGR over the forecast period, according to a new report by Grand View Research, Inc.
Growing need for sample collection to support and facilitate clinical trials for novel therapies, which are developed for treatment of chronic conditions, is anticipated to boost the market.Different biospecimens stored at biobanks are witnessing significant demand owing to advancements in cell-based research activities.
Rising demand from different end users has led to establishment of a substantial number of population-based and disease-based banks in recent years.
Population-based banks are established to support precision medicine research initiatives, whereas disease-specific biobanks provide resources to research communities to enable a better understanding of disease etiology.Furthermore, there has been a rapid increase in number of biobanks over the recent past, which can be attributed to perpetual developments in cell-based therapies, such as advent of stem cells and regenerative medicine.
Few examples of such networks are BBMIR-ERIC, Asian Network of Research Resource Centers, and Asian Consortium for the Conservation and Sustainable Use of Microbial Resources.Increase in number of clinical trials for new drug candidates has spurred demand for biobanking services.
Major challenges in biobanking operations include sustainability, limited access, and information sharing.
